Geulah Livshits
Stock Analyst at Chardan Capital
Total Price Targets
11
Stocks Covered
7
Sectors
Healthcare
Most Recent
Feb 18, 2026
Notable Calls (Last 12 Months)
Stocks Covered by Geulah Livshits
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | $323.00 | $265.25 | +21.8% | 3 | Feb 18, 2026 |
| CRSP | CRISPR Therapeutics AG | $76.00 | $51.72 | +47.0% | 2 | Feb 14, 2026 |
| FDMT | 4D Molecular Therapeutics, Inc. | $39.00 | $9.17 | +325.3% | 2 | Sep 19, 2024 |
| IPSC | Century Therapeutics, Inc. | $19.00 | $2.33 | +713.7% | 1 | Dec 27, 2022 |
| IMTX | Immatics N.V. | $28.00 | $10.82 | +158.8% | 1 | Aug 9, 2022 |
| IMRX | Immuneering Corporation | $18.00 | $5.39 | +234.0% | 1 | Jul 9, 2022 |
| MRNA | Moderna, Inc. | $188.00 | $44.65 | +321.1% | 1 | May 28, 2021 |
Recent Activity
- Feb 18, 2026— Set$323.00price target onKRYS(Krystal Biotech, Inc.)
- Feb 14, 2026— Set$76.00price target onCRSP(CRISPR Therapeutics AG)
- Sep 19, 2024— Set$39.00price target onFDMT(4D Molecular Therapeutics, Inc.)
- Jul 5, 2023— Set$30.00price target onFDMT(4D Molecular Therapeutics, Inc.)
- Dec 27, 2022— Set$19.00price target onIPSC(Century Therapeutics, Inc.)
- Nov 7, 2022— Set$133.00price target onKRYS(Krystal Biotech, Inc.)
- Aug 9, 2022— Set$79.30price target onCRSP(CRISPR Therapeutics AG)
- Aug 9, 2022— Set$28.00price target onIMTX(Immatics N.V.)
- Aug 8, 2022— Set$130.00price target onKRYS(Krystal Biotech, Inc.)
- Jul 9, 2022— Set$18.00price target onIMRX(Immuneering Corporation)
- May 28, 2021— Set$188.00price target onMRNA(Moderna, Inc.)
Frequently Asked Questions
Who is Geulah Livshits?
Geulah Livshits is a stock analyst at Chardan Capital covering 7 stocks primarily in Healthcare. They have issued 11 price targets since May 28, 2021.
What stocks does Geulah Livshits cover?
Geulah Livshits currently covers 7 stocks, including KRYS, CRSP, FDMT, IPSC, IMTX.
What is Geulah Livshits's latest price target?
Geulah Livshits's most recent price target was $323.00 on KRYS (Krystal Biotech, Inc.), set on Feb 18, 2026.
What is Geulah Livshits's highest price target?
Geulah Livshits's highest issued price target is $323.00 on KRYS, set on Feb 18, 2026.
More Analysts at Chardan Capital
Coverage based on publicly published price targets. Not investment advice.